Merck Receivables 2012-2026 | MRK

Merck receivables for the quarter ending March 31, 2026 were $12.120B, a 6.49% increase year-over-year.

  • Merck receivables for 2024 were $10.278B, a 0.69% decline from 2023.
  • Merck receivables for 2023 were $10.349B, a 9.51% increase from 2022.
  • Merck receivables for 2022 were $9.45B, a 2.38% increase from 2021.

Merck Receivables 2012-2026 | MRK

  • Merck receivables for 2024 were $10.278B, a 0.69% decline from 2023.
  • Merck receivables for 2023 were $10.349B, a 9.51% increase from 2022.
  • Merck receivables for 2022 were $9.45B, a 2.38% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B